Switch from etravirine twice daily to once daily in non-nucleoside reverse transcriptase inhibitor (NNRTI)-resistant HIV-infected patients with suppressed viremia: the Monetra study.

导出 LinkOut

翻译打印收藏纠错

作者： L,Schneider ^[1] ; N,Ktorza ; S,Fourati ; L,Assoumou ; E,Courbon ; F,Caby ; C,Blanc ; M,Tindel ; R,Agher ; A G,Marcelin ; V,Calvez ; G,Peytavin ; C,Katlama

作者单位： Infectious Diseases Department, Pitié-Salpêtrière Hospital, Paris, France. ^[1]

主题词用药计划表(Drug Administration Schedule);抗药性, 病毒(Drug Resistance, Viral);基因型(Genotype);HIV感染(HIV Infections);HIV-1(HIV-1);人类(Humans);腈类(Nitriles);试点项目(Pilot Projects);哒嗪类(Pyridazines);嘧啶类(Pyrimidines);逆转录酶抑制剂(Reverse Transcriptase Inhibitors);病毒血症(Viremia)

DOI 10.1310/hct1305-284

PMID 23134629

发布时间 2020-12-09

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

HIV clinical trials

284-8页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Switch from etravirine twice daily to once daily in non-nucleoside reverse transcriptase inhibitor (NNRTI)-resistant HIV-infected patients with suppressed viremia: the Monetra study.

HIV clinical trials

相似文献

HIV clinical trials

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Switch from etravirine twice daily to once daily in non-nucleoside reverse transcriptase inhibitor (NNRTI)-resistant HIV-infected patients with suppressed viremia: the Monetra study.

HIV clinical trials

相似文献

HIV clinical trials

相关期刊

检索历史清除